This page screens the US healthcare sector for stocks yielding at least 2% with debt-to-equity of 2.5 or less, refreshed automatically from live data.
DeltaScreener builds this page from the US-listed stocks it tracks, using the following rules. A stock appears here only because it matches these rules; the page title names the criteria and is not a rating of any stock.
Top sectors in the current result set: Healthcare (24).
Click any ticker to open the full stock detail page with financials, valuation ratios, and more.
| # | Ticker | Company | Exchange | Price | Market Cap | P/E | P/B | ROE | ROA | Net Margin | D/E |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ORMP | Oramed Pharmaceuticals Inc. | NASDAQ | $4.07 | $169.3M | 1.06 | 0.58 | 72.96% | 47.31% | — | 0.01 |
| 2 | CPIX | Cumberland Pharmaceuticals Inc. | NASDAQ | $7.18 | $107.6M | — | 6.35 | -47.10% | -16.87% | -33.92% | 0.27 |
| 3 | SIGA | SIGA Technologies Inc. | NASDAQ | $3.17 | $227.8M | — | 1.47 | — | -1.57% | -5.14% | 0.01 |
| 4 | SPOK | Spok Holdings, Inc. | NMS | $10.61 | $221.6M | 18.28 | 1.62 | 8.50% | 6.26% | 9.00% | 0.04 |
| 5 | PRGO | Perrigo Company plc | NYSE | $16.63 | $2.30B | — | 0.79 | -55.97% | -22.80% | -41.85% | 1.31 |
| 6 | YARW | Yarrow Bioscience, Inc. | NASDAQ | $18.31 | $170.4M | — | 0.79 | -70.23% | -79.26% | — | 0 |
| 7 | XRAY | DENTSPLY SIRONA Inc. | NASDAQ | $8.57 | $1.71B | — | 1.34 | -39.81% | -10.49% | -14.99% | 1.71 |
| 8 | PFE | Pfizer, Inc. | NYSE | $29.58 | $168.60B | 37.88 | 1.92 | 4.89% | 2.16% | 6.81% | 0.74 |
| 9 | PHG | Koninklijke Philips N.V. NY Registry Shares | NYSE | $25.74 | $24.90B | 18.22 | 1.78 | 10.05% | 4.17% | 6.31% | 0.65 |
| 10 | KMDA | Kamada Ltd. | NASDAQ | $7.76 | $447.7M | 21.7 | 1.78 | 8.37% | 5.81% | 11.60% | 0.04 |
| 11 | BMY | Bristol-Myers Squibb Company | NYSE | $59.75 | $122.05B | 13.85 | 5.75 | 46.75% | 10.59% | 18.87% | 1.93 |
| 12 | NVS | Novartis AG | NYSE | $150.62 | $286.29B | 21.93 | 6.61 | 29.64% | 10.34% | 23.09% | 1.18 |
| 13 | MDT | Medtronic plc | NYSE | $94.75 | $121.20B | 21.67 | 2.26 | 10.60% | 5.61% | 13.93% | 0.56 |
| 14 | NVO | Novo Nordisk A/S | NYSE | $38.83 | $171.36B | 9.65 | 5.06 | 59.09% | 19.57% | 35.35% | 0.63 |
| 15 | CVS | CVS Health Corporation | NYSE | $92.36 | $118.13B | 23.27 | 1.43 | 6.43% | 1.93% | 1.18% | 0.96 |
| 16 | VTRS | Viatris Inc. | NASDAQ | $18.66 | $21.43B | — | 1.48 | -2.79% | -1.17% | -2.79% | 0.96 |
| 17 | ABT | Abbott Laboratories | NYSE | $104.88 | $181.48B | 32.57 | 3.45 | 10.52% | 4.97% | 11.65% | 0.64 |
| 18 | UNH | UnitedHealth Group Incorporated Common Stock (DE) | NYSE | $401.43 | $360.32B | 24.22 | 3.47 | 14.63% | 4.56% | 3.14% | 0.74 |
| 19 | SNN | Smith & Nephew SNATS, Inc. | NYSE | $29.06 | $12.16B | 17.48 | 2.17 | 12.25% | 5.81% | 10.08% | 0.73 |
| 20 | CI | The Cigna Group | NYSE | $302.30 | $79.88B | 11.22 | 1.68 | 15.24% | 4.08% | 2.27% | 0.75 |
| 21 | MRK | Merck & Company, Inc. Common Stock (new) | NYSE | $145.97 | $360.12B | 118.05 | 8.77 | 6.60% | 2.44% | 4.78% | 1.29 |
| 22 | BDX | Becton, Dickinson and Company | NYSE | $191.75 | $52.23B | 55.37 | 2.07 | 3.79% | 1.85% | 4.52% | 0.69 |
| 23 | USPH | U.S. Physical Therapy, Inc. | NYSE | $85.71 | $1.28B | 492.47 | 2.81 | — | -0.48% | -0.77% | 0.86 |
| 24 | GILD | Gilead Sciences, Inc. | NASDAQ | $156.19 | $193.67B | — | 15.86 | — | -6.56% | -10.64% | 2.22 |